Higher BCG‐induced trained immunity prevalence predicts protection from COVID‐19: Implications for ongoing BCG trials

• Päätekijät: Samer Singh (Tekijä), Dhiraj Kishore (Tekijä), Rakesh K. Singh (Tekijä), Chandramani Pathak (Tekijä), Kishu Ranjan (Tekijä)
• Aineistotyyppi: Kirja
• Julkaistu: Wiley, 2022-06-01T00:00:00Z.
• Aiheet: article
• Linkit: Connect to this object online.

Abstract Endeavors to identify potentially protective variables for COVID‐19 impact on certain populations have remained a priority. Multiple attempts have been made to attribute the reduced COVID‐19 impact on populations to their Bacillus-Calmette-Guérin (BCG) vaccination coverage ignoring the fact...